CI
DXCM icon

Corient IA’s DexCom DXCM Stock Holding History

Corient IA’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$202K Sell
3,220
-780
-20% -$54.3K 0.19% 200
2025
Q4 		$265K Hold
4,000
– – 0.25% 168
2025
Q3 		$269K Hold
4,000
– – 0.2% 196
2025
Q2 		$349K Hold
4,000
– – 0.21% 190
2025
Q1 		$273K Buy
+4,000
New +$326K 0.19% 230

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Corient IA's DXCM Position: Q1 2026 in Review

Corient IA reduced its DexCom (DXCM) stake by 20% in Q1 2026, selling an estimated $54.3K and leaving 3,220 shares worth $202K. The position accounts for 0.19% of the portfolio, ranked #200.

Corient IA first reported a position in DXCM in Q1 2025 and has held it in 5 quarters since. The position peaked at $349K in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Corient IA held 3,220 shares of DexCom worth $202K as of Q1 2026.
  • Corient IA sold 780 DexCom shares in Q1 2026, an estimated $54.3K.
  • DexCom made up 0.19% of Corient IA's portfolio in Q1 2026, its #200 holding.
  • Corient IA first reported a position in DexCom in Q1 2025 and has held it in 5 quarters since.
  • Corient IA's DexCom position peaked at $349K in Q2 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Corient IA's 13F filing for Q1 2026, filed 14 May 2026.